Trials / Recruiting
RecruitingNCT05820776
Tele-rehabilitation in Chronic Respiratory Disease: an Observational Cohort Study
Remote Exercise-based Pulmonary Rehabilitation Telemedicine in Chronic Respiratory Disease: an Observational Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- West Park Healthcare Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Pulmonary rehabilitation is a program that helps people with lung disease improve their function. It uses exercise, education, and self-management strategies to improve physical ability and quality of life. Because some people are unable to visit West Park Healthcare Centre, we established a remote supervised pulmonary rehabilitation program that patients can access via an electronic device (computer, tablet or smart phone). Regular quality assurance is necessary to ensure that the program is effective. We plan to collect and summarize the program's results. The benefit of doing so is that it allows us to make any changes or improvements that may help patients with chronic respiratory conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | pulmonary rehabilitation | The intervention is PR delivered via a telemedicine. The intervention is PR delivered via a telemedicine. The program is delivered by the multidisciplinary via a remote application for two sessions per week for ten weeks. Remotely supervised exercise includes: 1) deep breathing reinforcing pursed lip and diaphragmatic breathing; 2) warm up breathing and stretching exercise; 3) a cardiorespiratory aerobic exercise battery; 4) resistance training, and; stretching cool down. There is also an educational component. The secondary (maintenance) program includes ongoing remotely supervised exercise and education once a week for six months (24 sessions). All patients successfully completing the initial PR are offered the maintenance program. |
Timeline
- Start date
- 2023-04-06
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2023-04-20
- Last updated
- 2024-07-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05820776. Inclusion in this directory is not an endorsement.